Pharmaceuticals News and Research

RSS

Pharmacies face extra audit burdens that threaten their existence

The clock was about to strike midnight, and Scott Newman was desperately feeding pages into a scanner, trying to prevent thousands of dollars in prescription payments from turning into a pumpkin.

6 Aug 2021

Study demonstrates the potency of herbal medicines against Bartonella henselae

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data showing that herbal medicines have potent activity in test tubes compared to pharmaceuticals commonly-prescribed for the treatment of Bartonella henselae, a bacterium believed to be carried by ticks and the cause of cat scratch fever.

5 Aug 2021

Experimental drug combination extends survival in mice with lung cancer, study finds

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.

5 Aug 2021

KHN’s ‘What the Health?’: Delta blues

The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.

5 Aug 2021

2+2=? Senate uses murky math as it shelves drug pricing rule to fund infrastructure

The Senate’s release of its bipartisan infrastructure plan signals that lawmakers are poised to throw former President Donald Trump’s belated bid to lower Medicare drug prices under the bus — not to mention trains, bridges, tunnels and broadband connections.

5 Aug 2021

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

It's a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy?

2 Aug 2021

Diabetes drug’s new weight loss formula fuels cost-benefit debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.

30 Jul 2021

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

An international study led by the Lipids&Liver research team at the UPV/EHU-University of the Basque Country, the results of which have recently been published in the prestigious journal Cancer Research, has demonstrated that inhibiting either of the proteins E2F1 or E2F2 in the liver protects against the development of obesity-driven nonalcoholic fatty liver disease and its progression to cancer.

29 Jul 2021

Pfizer court fight could legalize Medicare copays and unleash ‘gold rush’ in sales

Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.

29 Jul 2021

First interchangeable biosimilar insulin product approved by FDA for treatment of diabetes

Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.

28 Jul 2021

As holdout Missouri joins nation in monitoring opioid prescriptions, experts worry

Kathi Arbini said she felt elated when Missouri finally caught up to the other 49 states and approved a statewide prescription drug monitoring program this June in an attempt to curb opioid addiction.

26 Jul 2021

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Do you sometimes lose your train of thought or feel a bit more anxious than is typical for you?

23 Jul 2021

Researchers use nanoparticles as heaters to manipulate the electrical activity of neurons

Nanomaterials have been used in a variety of emerging applications, such as in targeted pharmaceuticals or to bolster other materials and products such as sensors and energy harvesting and storage devices.

22 Jul 2021

Analysis: Necessary or not, covid booster shots are probably on the horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot.

21 Jul 2021

Sen. Wyden: $3.5T budget may have to trim but it can set a path to ‘ambitious goals’

Exactly what American health care will look like if Democrats can pass their $3.5 trillion spending plan is unclear, but the senator negotiating its health-related provisions hopes what emerges will be dramatic: the first complete health care system for older Americans and significantly reduced costs for everyone else.

20 Jul 2021

Biden’s July executive order includes drug pricing provisions. But will they do enough?

Previous
1
...
71
72
73
74
75
76
77
...
1290
Next

Pharmaceuticals News and Research

Pharmacies face extra audit burdens that threaten their existence

Study demonstrates the potency of herbal medicines against Bartonella henselae

Experimental drug combination extends survival in mice with lung cancer, study finds

KHN’s ‘What the Health?’: Delta blues

2+2=? Senate uses murky math as it shelves drug pricing rule to fund infrastructure

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

Diabetes drug’s new weight loss formula fuels cost-benefit debate

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

Pfizer court fight could legalize Medicare copays and unleash ‘gold rush’ in sales

First interchangeable biosimilar insulin product approved by FDA for treatment of diabetes

As holdout Missouri joins nation in monitoring opioid prescriptions, experts worry

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Researchers use nanoparticles as heaters to manipulate the electrical activity of neurons

Analysis: Necessary or not, covid booster shots are probably on the horizon

Sen. Wyden: $3.5T budget may have to trim but it can set a path to ‘ambitious goals’

Biden’s July executive order includes drug pricing provisions. But will they do enough?

Imaging technology may be able to treat life-threatening blood clotting condition

Senate Democrats’ plan boosts spending on Medicare, ACA subsidies, long-term care

Dying patients with rare diseases struggle to get experimental therapies

Researchers discover new set of signals that control production of goblet cells in the lung

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring